Senior Research Associate, Analytical Development
Moderna
Summary
In this hands-on individual contributor role within Analytical Development, you will help advance the microbiological methods essential to the development of Moderna's mRNA-based vaccines and therapeutics. Working alongside experienced scientists, you will execute laboratory studies spanning method development, optimization, characterization, qualification, and validation, with a particular focus on bioburden, endotoxin, sterility, and environmental monitoring.
Job description
Here's What You'll Do
- Execute microbiological method development, optimization, characterization, qualification, and validation studies for bioburden, endotoxin, sterility, environmental monitoring, and related microbiological methods.
- Plan and execute defined experimental studies, applying sound scientific principles to analyze and interpret results, assess method performance, identify sources of variability, troubleshoot technical challenges, and contribute to recommendations for subsequent experimental activities.
- Support the evaluation of microbiological method performance, robustness, and suitability for intended use across relevant materials and sample types.
- Execute laboratory study protocols and analytical methods, contributing to the preparation of technical reports, method development summaries, qualification and validation documentation, and other scientific records.
- Perform hands-on microbiological testing to support method development, qualification and validation activities, technical investigations, troubleshooting, and other non-routine analytical assessments.
- Contribute to microbiological investigations, deviation assessments, root-cause analysis, and method troubleshooting, collaborating with AD, AS&T, QC, Quality, Process Development, and other cross-functional partners.
- Generate, analyze, and organize high-quality experimental data and supporting documentation for technical assessments, risk evaluations, regulatory questions, and development program requirements.
- Support the transfer and implementation of microbiological methods into internal and external Quality Control laboratories.
- Participate in the assessment and implementation of alternative and rapid microbiological methods, emerging analytical technologies, and laboratory automation approaches.
- Gain exposure to advanced digital technologies, including Generative AI-enabled tools for scientific knowledge management, data interpretation, documentation support, and laboratory workflow optimization.
- Communicate experimental results, scientific observations, study progress, technical risks, and emerging challenges clearly to colleagues and cross-functional stakeholders.
- Maintain high standards of laboratory safety, accurate experimental documentation, data quality, and scientific rigor.
Here's What You'll Need (Basic Qualifications)
- B.S./B.A. in Microbiology, Biology, Molecular Biology, Biochemistry, Biotechnology, or a related field with 2+ years of relevant laboratory or industry experience; or an M.S. in a related field with relevant hands-on laboratory experience.
- Hands-on experience with microbiological techniques and laboratory testing, method development, troubleshooting, or related experimental work is required.
- Candidates must already hold work authorization in US and be able to maintain that status without the need for future sponsorship.
Here's What You'll Bring to the Table (Preferred Qualifications)
- Hands-on experience with microbiological methods including bioburden, bacterial endotoxin, and sterility; environmental monitoring experience is desirable.
- Exposure to developing, optimizing, characterizing, qualifying, or validating microbiological methods in a biotechnology or pharmaceutical environment.
- Basic understanding of microbiological method performance, suitability, controls, interference, recovery, variability, and fitness for intended use.
- Experience troubleshooting laboratory methods and supporting investigations or root-cause assessments.
- Familiarity with GMP, good documentation practices, and applicable compendial microbiological methods and regulatory expectations.
- Exposure to method transfer or implementation in QC or external testing laboratories is desirable.
- Experience with rapid or alternative microbiological methods, microbial identification, molecular techniques, or related technologies is desirable.
- Experience with mRNA, lipid nanoparticles, vaccines, biologics, or other advanced therapeutic modalities is preferred.
- Strong organizational, data analysis, problem-solving, and communication skills, with attention to accurate experimental documentation.
- Behaves like an owner, demonstrates initiative, takes accountability for assigned activities, and proactively supports team priorities.
- Collaborative, adaptable, and eager to learn, with the ability to respond to changing priorities and contribute effectively in a dynamic laboratory environment.
Requirements
- B.S./B.A. in Microbiology, Biology, Molecular Biology, Biochemistry, Biotechnology, or a related field with 2+ years of relevant laboratory or industry experience; or an M.S. in a related field with relevant hands-on laboratory experience
- Hands-on experience with microbiological techniques and laboratory testing, method development, troubleshooting, or related experimental work
- Must already hold work authorization in US and be able to maintain that status without the need for future sponsorship
Benefits
- Competitive healthcare
- Voluntary benefit programs
- Fitness support
- Mindfulness support
- Mental health support
- Fertility support
- Adoption support
- Surrogacy support
- Paid time off
- Volunteer days
- Sabbatical
- Global recharge days
- Year-end shutdown
- Savings and investments
- Annual discretionary bonus
- Equity award
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.